haloperidol and ngb 2904
haloperidol has been researched along with ngb 2904 in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Braun, J; Brodbeck, R; Chen, X; Primus, R; Thurkauf, A; Wasley, JW; Yuan, J | 1 |
Berardi, F; Colabufo, NA; Contino, M; Lacivita, E; Leopoldo, M; Perrone, R | 1 |
Claytor, R; Martelle, JL; Nader, MA; Newman, AH; Reboussin, BA; Ross, JT | 1 |
Banasikowski, TJ; Beninger, RJ | 1 |
Huang, M; Kwon, S; Meltzer, HY; Miyauchi, M; Oyamada, Y; Rajagopal, L | 1 |
Other Studies
5 other study(ies) available for haloperidol and ngb 2904
Article | Year |
---|---|
NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists.
Topics: Animals; CHO Cells; Cricetinae; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluorenes; Humans; Kinetics; Piperazines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Transfection | 1998 |
First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
Topics: Amides; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Piperazines; Radioligand Assay; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship | 2005 |
Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discrimin
Topics: Animals; Cocaine; Conditioning, Psychological; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluorenes; Haloperidol; Macaca mulatta; Male; Piperazines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement, Psychology | 2007 |
Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Topics: Animals; Behavior, Animal; Catalepsy; Conditioning, Classical; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fluorenes; Haloperidol; Male; Motor Activity; Naphthalenes; Piperazines; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D3; Spatial Behavior; Time Factors | 2012 |
Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement.
Topics: Acetylcholine; Animals; Benzopyrans; Brain Chemistry; Cerebral Cortex; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Fluorenes; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nootropic Agents; Oxazines; Phencyclidine; Piperazines; Piperidines; Rats, Long-Evans; Receptors, Dopamine D3 | 2015 |